Complying with regulations for bioassay monitoring of radionuclide intakes is significantly more complex for mixtures than it is for pure radionuclides. Different constituents will naturally have different dose coefficients, be detectable at significantly different levels, and may require very different amounts of effort to bioassay. The ability to use certain constituents as surrogates for others will depend on how well characterized the mixture is, as well as whether the employee is also working with other radionuclides. This is further compounded by the fact that the composition of a mixture (or even of a pure radionuclide) is likely to change over time. Internal dosimetrists must decide how best to monitor employees who work with radionuclide mixtures. In particular, they must decide which constituents should be monitored routinely, which constituents only need to be monitored in the case of an intake, and how to estimate doses based on intakes of monitored and unmonitored constituents. Health Phys. 113(4): 315-323; 2017 
INTRODUCTION
This paper deals with the specific considerations regarding enrollment criteria, monitoring criteria, and dose calculation for work involving radionuclide mixtures. A mixture is defined as a collection of radionuclide constituents that are present at the same time in the same process, such that an intake of one of the constituents must necessarily coincide with an intake of all the other constituents.
All United States Department of Energy (U.S. DOE) radiation workers likely to receive a total of 1 mSv from internal and external sources in a given year are required by 10 CFR Part 835 (U.S. Federal Register 2007) to receive radiation dose monitoring. Note that this is different from the less conservative requirement of 10 CFR Part 20 (U.S. NRC 2007), which requires monitoring when the total dose could exceed 10% of the annual dose limit of 50 mSv. The 1 mSv CED monitoring threshold is also in agreement with IAEA recommendations (IAEA 1999) .
Because of differences in uptake and biokinetic behavior for a given radionuclide in different physical and chemical forms, the dose delivered to a given person by a certain quantity of radionuclide is not always the same. Even for a known physical and chemical form, the biokinetic models are often highly uncertain (e.g., Poudel et al. 2016) , leading to large uncertainty in the potential dose. For that reason, the quantity of a single radionuclide in process that leads to the potential for a 1 mSV CED can be established using some standard method, such as those laid out in NRC Regulatory Guides (e.g., U.S. NRC 1992a, b, c; U.S. NRC 2011) or NUREG 4884 (U.S. NRC 1987) . These guides present standard approaches for calculating doses which can be used to determine monitoring thresholds for specific radionuclides. While the U.S. NRC Regulatory Guides are based on ICRP Publication 30 (ICRP 1979) , in this paper they have been applied using the ICRP 60 series of models and methodology (ICRP 1991 (ICRP , 1993 (ICRP , 1994 . Using these guides and, in some cases, more conservative approaches, monitoring thresholds for pure radionuclides used at Los Alamos National Laboratory (LANL) have already been established. However, determining monitoring thresholds for radionuclide mixtures presents special challenges.
At U.S. DOE facilities implementing 10 CFR Part 835 (U.S. Federal Register 2007), bioassay monitoring is required whenever the potential dose of a mixture exceeds 1 mSv, where the potential dose of a mixture is regarded as the sum of the potential dose of its constituents. In other words, it is not necessary for the potential dose of any single constituent to exceed 1 mSv in order for monitoring to be required under the regulations. However, in some cases it might be neither feasible nor necessary to monitor for each constituent of a mixture. In other cases, the dosimetrically dominant constituents might change with time due to different half-lives. Described here are methods used to monitor for intakes of specific mixtures that might be found at LANL and how to estimate doses under various circumstances.
MATERIALS AND METHODS

Characterizing a mixture
In general, a given mixture will be described by the relative abundance of its constituents, either by mass or by activity. For radiation protection, it is useful to calculate the committed effective dose coefficients of each constituent (50-y committed effective dose caused by the constituent per unit activity of the total mixture, hereafter called dose coefficients), as well as the total dose coefficient of the mixture. Table 1 shows the specific activities and dose coefficients of americium and common isotopes of plutonium based on ICRP Publication 60 (ICRP 1991 (ICRP , 2011 Bertelli et al. 2008) . These are useful in calculating the dose coefficient of a mixture for a given radionuclide and the total dose coefficient of the mixture. By convention, the dose coefficients are given for 5 mm AMAD aerosols with Type M solubility.
Each radionuclide, i, that is a constituent of the mixture has an associated dose coefficient, dc i , with units of Sv g −1
. Each of these constituents is a fraction, f i , of the mixture by activity (i.e., the percent of the activity divided by one hundred). The dose coefficient of the mixture for that constituent is given by DC i = dc i Â f i , where DC i is the dose from constituent i caused by a 1-g intake of the mixture. The total dose coefficient of the mixture, DC, is the sum of the dose coefficients of the constituents:
This is the total dose that would result from an intake of 1 g of the mixture. For evaluating which constituents in a mixture are dosimetrically dominant, it may be convenient to consider their relative dose potential, given by dc i / DC. This is the fraction of the total dose that would be caused by constituent i following an intake of the mixture. Note that an analogous formula applies when the mixture is described by the relative abundance of its constituents by mass. In some cases, it is convenient to scale the dose coefficient by specific activity, so that it has units of dose per unit of mass.
The use of eqn (1) is illustrated in the Appendix, where Table A1  shows relative mass of the different  constituents of some plutonium  mixtures encountered at LANL,  and Table A2 shows the calculated dose coefficients.
Along with dose coefficient, the routine in vitro bioassay monitoring threshold is a key characteristic of a mixture. In particular, monitoring thresholds must be calculated for the total mixture, as well as for the individual constituents. These calculations are analogous to calculations of the dose coefficients. In determining monitoring thresholds, some assumptions must be made to estimate the fraction of material that could be taken into the body. At LANL, it is traditionally assumed that approximately 10 −4 of the mass of material may become dispersed into the glovebox atmosphere due to operations being performed (Healy 1971) , that the glovebox will not release more than 10 −2 of the dispersed material, and that 10 −6 of the material present outside the glovebox may be inhaled. Under these assumptions, it can be easily shown that the historical monitoring threshold of 10 g 239 Pu is consistent with the requirement to monitor anyone who might receive 1 mSv CED. To generalize this result to other radionuclides, the monitoring threshold is defined as the mass that would give the same dose as 10 g of 239 Pu. Table 2 shows the radionuclide monitoring thresholds, m i , for various common radionuclides calculated using LANL guidelines. The thresholds for Am were calculated from first principles as being capable of causing 1 mSv doses, while the others were determined so as to have an equivalent internal dose potential as 10 g of 239 Pu. For constituent i with radionuclide monitoring threshold m i which is f i of a mixture by mass, the mass of the mixture which contains m i is given by M i = m i /f i , where M i is defined as the constituent monitoring threshold. The monitoring threshold for the mixture, M, is given by
When the total mass of a mixture exceeds the mixture monitoring threshold, M, some sort of bioassay monitoring is required for that mixture. The use of eqn (2) is illustrated in the Appendix, where Table A3 shows the constituent monitoring thresholds and material monitoring thresholds for the example mixtures.
Aging mixtures
Many mixtures have constituents with half-lives on the order of centuries or years. When that happens, the radiological characteristics of the mixture can be expected to change significantly during the useful lifetime of the mixture. A common example is 241 Pu, which decays with a 14-y half-life to 241 Am (which, because it is an alpha emitter, has a significantly larger dose coefficient), which in turn decays with a 432-y half-life to 237 Np (which is dosimetrically insignificant compared to its parents). This is an important consideration at LANL, where plutonium samples can range from brand new to many decades old. The activities of daughter radionuclides can be calculated using the Bateman Equation (Bateman 1910; Moral and Pacheco 2003) . For a single progeny, the activity as a function of time, A d (t), is
where Ap (t) is the activity of the parent as a function of time. Assuming no "daughter" and "granddaughter" are present at time 0, the activity of a granddaughter as a function of time, A g (t), is
These equations can be used to calculate the gross activity of each constituent of a mixture as a function of time. Combined with the specific activities of the components, this leads to the mass fraction of each component of the mixture which, using eqn (1), can be used to calculate the dose coefficients of the constituents and the total dose coefficient of the mixture. Quantities of particular interest include the age at which the dose coefficient reaches a maximum, and the age at which the dosimetrically insignificant constituents become significant. The use of eqn (2) is illustrated in the Appendix, where Table A6 shows dose coefficients for the example mixtures when brand new, and Table A7 shows the dose coefficients after the mixtures are aged 30 y. Table A5 shows the ages at which dosimetrically insignificant constituents become significant, and Tables A7 and A8 show how the contributions to the total mixture dose coefficient of the constituents change with age.
Uncertain mixtures and mixture combinations
More often than not, employees work with a variety of mixtures, all with different ages and compositions. The combination of mixtures an employee is, or might be, working with can be characterized as a "meta-mixture." This imaginary mixture represents the most conservative reasonable estimates of the potential dose of the mixtures and their constituents. The dose coefficient of the metamixture used to determine monitoring thresholds should be given by the mixture with the largest dose coefficient (at any possible age) the employee will be working with. Monitoring thresholds for individual constituents should be calculated based on the mixture with the highest dose coefficient for that constituent (at any age).
For example, consider an employee working with a combination of imaginary mixtures Mixture 1 and Mixture 2 (age unknown), shown in Table 3 . The dose coefficients which should be used to determine monitoring thresholds are highlighted grey.
Classifying mixture constituents
In general, employees may be working with a variety of different mixtures and pure radionuclides. In some cases, knowledge of an intake of one constituent provides information about the intake of another, unmeasured, constituent. When this is possible, the measured constituent is defined as a surrogate for the unmeasured constituent. The monitoring capability for a given constituent must fall into one of three categories.
Class 1: The intake of a Class 1 constituent is uniquely determined by the intake of another constituent (i.e., a surrogate) of the mixture. This is possible when the exact relative abundance of the constituent to the surrogate is known, and no intakes of the surrogate can happen other than through an intake of the mixture.
In some cases, it may be possible for constituent A to serve as a surrogate for constituent B, or for constituent B to serve as a surrogate for constituent A. Class 2: An upper limit on the intake of a Class 2 constituent can be determined by the intake of a surrogate. This can happen when the relative abundance of the constituent to the surrogate is known to be in a certain range. In general, this is not possible when intakes of the surrogate can happen other than through an intake of the mixture (e.g., by also working with a different mixture or a pure form of the surrogate radionuclide).
Class 3: A Class 3 constituent has no surrogate constituents in the mixture. Intakes of a class 3 constituent can only be determined by directly monitoring for that constituent. This happens when no information is available about relative abundance of the constituent in the mixture, or when intakes of the surrogate can happen by other means than through an intake of the mixture.
Note that the classes of the constituents are determined by how much can be inferred about an intake of that constituent by measuring a surrogate. This depends not only on the amount known about the composition of the mixture, but also on the other radionuclides the employee is working with. It follows that, for a given mixture, the constituents may be different Classes for different employees.
Example: Classifying constituents. Consider a mixture which is composed of 25% radionuclide A, 25% radionuclide B, and 50% some combination of radionuclide C and D. Sarah works only with that mixture. Joe works with that mixture and also radionuclide A in its pure form.
For Sarah, radionuclides A and B are Class 1-an intake of either uniquely determines the intake of the other. Radionuclides C and D are Class 2-an intake of either can be no more than double the intake of radionuclide A or B (either of which could be used as surrogates).
For Joe, radionuclide B cannot serve as a surrogate for radionuclide A, since he could have an intake of radionuclide A while working with it in its pure form. For the same reason, radionuclide A cannot be used as a surrogate for radionuclide B. It follows that, for Joe, Radionuclides A and B are Class 3. In this case, radionuclide B can still serve as a surrogate for radionuclides C and D, which are thus still Class 2.
DISCUSSION
Bioassay monitoring
A worker must be monitored for intakes whenever the potential dose of a mixture exceeds 1 mSv. However, as explained above, it is not always necessary to monitor for every constituent of a mixture. This paper examines the dose assessment implications of certain decisions in specific scenarios. In practice, determining which constituents to monitor is a complicated decision involving a number of technical and practical considerations. These decisions must be made on a case-by-case basis and may need to be revisited as considerations change (e.g., when a new technical capability becomes available).
Determining which constituents of a mixture should be directly monitored is a complicated decision. If nothing else, the constituent that is dosimetrically dominant (i.e., the constituent with the smallest constituent monitoring threshold) should typically be monitored. It could be appropriate to also monitor other constituents if they offer a lower detection threshold, even is the monitoring threshold for that constituent is not exceeded.
When the total mass of a mixture exceeds the constituent monitoring threshold of constituent i, M i , bioassay monitoring should be considered for that constituent. However, it may be acceptable to monitor for that constituent indirectly by monitoring for a surrogate.
Following an incident or elevated routine bioassay measurement involving a mixture, special bioassay monitoring for an unmonitored constituent should be ordered if the potential dose from that constituent could exceed 1 mSv. However, determining whether that is the case is largely a matter of professional judgement.
When deciding whether to order bioassay measurements for an unmonitored constituent, the dosimetrist must consider the maximum potential dose from the constituent, the improvement in accuracy (if any) to the total dose estimate from the additional measurements, the maximum "missed dose" that might result if a bioassay is not ordered, and the difficulty of performing bioassay measurements on those constituents.
Often there will be significant uncertainty on the maximum dose from an unmonitored constituent due to uncertainty on its relationship to the dose from the surrogate, as well as initial uncertainty on the dose of the surrogate. Bioassay measurements for unmonitored constituents may be considered if, in the judgement of the dosimetrist, the maximum potential dose could be greater than 100 mSv. In that case, serious consideration should be given to ordering follow-up bioassay of unmonitored Class 2 constituents, for which there may be significant uncertainty on the true dose.
The decision to order followup bioassay on unmonitored constituents depends on a number of factors, both technical and practical. In particular, it is based on the dosimetrist's judgement of the maximum potential dose from
Bioassay monitoring of mixtures of radionuclides those constituents, which cannot be accurately estimated at the beginning of an investigation. For that reason, the internal dosimetrist must have the discretion to order follow-up bioassay measurements on any constituent at any time. In particular, bioassays may be ordered at any time during the course of an intake investigation, even when the best estimate for the maximum detectable dose is less than 1 mSv.
Dose assessment
Following an intake of a mixture, the dosimetrist must decide whether/how to assign a dose from the unmonitored constituents. As a rule, doses from constituents which were directly measured should be calculated and assigned independently. In general, dose estimates from unmonitored constituents are so small compared to the overall uncertainty that they should not be incorporated into the total dose estimate. However, every effort should be made to monitor and report doses greater than 1 mSv. It follows that if the estimated dose from an unmonitored constituent is greater than 1 mSv, bioassay measurements should be ordered for that constituent. The only exception may be the rare case in which bioassay monitoring is not capable of detecting intakes of that constituent at the expected dose level. In that case, it may be acceptable to assign a dose based off a surrogate.
CONCLUSION
Complying with regulations for bioassay monitoring of radionuclide intakes is significantly more complex for mixtures than it is for pure radionuclides. Different constituents will naturally have different dose coefficients, be detectable at significantly different levels, and may require very different amounts of effort to bioassay. The ability to use certain constituents as surrogates for others will depend on how well characterized the mixture is, as well as whether the employee is also working with other radionuclides. This is further compounded by the fact that the composition of a mixture (or even of a pure radionuclide) is likely to change over time.
This paper has reviewed the theoretical considerations involved in deciding how best to monitor employees who work with radionuclide mixtures. In particular, it has considered which constituents must be monitored routinely, which constituents only need to be monitored in the case of an intake, and how to estimate doses based on intakes of monitored and unmonitored constituents. In general, the number of different factors and possible scenarios is so great that any real-world scenario will have a unique best course of action which can only be determined by the internal dosimetrist. Some specific examples are shown in the Appendix. 
REFERENCES
APPENDIX
Example: Plutonium mixtures
As an example of the process for deciding when and how to monitor a mixture, consider Table A1 , which presents some the plutonium mixtures (Heindel et al. 1995) , showing the relative mass of the different constituents.
Step 1: Calculate dose coefficients. The first step in analyzing these mixtures is to determine the potential dose and relative dose coefficient of each of the constituents. These can be calculated by scaling the isotopic mass fractions by specific activity and dose coefficients. Table A2 shows the plutonium mixtures with their total dose coefficients in units of CED per unit mass, as well as the dose coefficients for specific isotopes.
Step 2: Calculate monitoring thresholds. The monitoring thresholds for the different mixtures can be calculated based on the monitoring thresholds of the constituents using the methods described above. In some cases, the mass of the mixture may be sufficient that one or more of the constituents could cause 1 mSv intakes on its own. Table A3 shows the monitoring thresholds for these mixtures, as well as the monitoring thresholds for their constituents. Note that the monitoring thresholds for a mixture is always lower than the monitoring thresholds of its constituents.
Assuming that an employee was working with just one of these mixtures (which in reality is almost never the case), the mixture monitoring threshold is the mass of the mixture which requires some sort of monitoring. The monitoring threshold for a given isotope constituent is the mass of the mixture which would cause the monitoring threshold for that isotope constituent to be exceeded. However, it is not always clear which nuclides must be monitored. For example, it may happen that the monitoring threshold for a mixture is exceeded without exceeding the monitoring threshold for any of its constituents. Also, exceeding the monitoring threshold for a constituent does not always necessitate routine monitoring for that constituent-it may be acceptable to use a surrogate.
Step 3: Calculate relative dose contributions. The fraction of the dose coefficient contributed by each constituent is easily calculated from the constituent dose coefficients shown above. These are presented in Table A4 . The dominant constituents are highlighted grey. The dose coefficient of each mixture was also calculated in CED per unit mass. While Pu are not dosimetrically dominant for any of the mixtures, they may still need to be monitored following an incident or elevated routine, or if enough material is being worked with that 1 mSv intakes are possible. The relative dose coefficients can be used to estimate the possible dose from unmonitored constituents following an intake. This Table A1 . Different plutonium mixtures which might be encountered at LANL. Table A2 . The mixture dose coefficients and constituent dose coefficients for the plutonium mixtures. is an important consideration in deciding whether to request special bioassay for those constituents.
Material
Step 4: Consider the effects of age. It is important to remember that the total hazard of mixture changes as it ages, as do the relative hazards of its constituents. The most significant changes which occur in the first century of a plutonium mixture are that the relative hazard of 241 Pu decreases rapidly, while the relative hazard of 241 Am increases. Usually, the total dose coefficient of a mixture begins to decrease immediately with age. However, that need not always be the case. For example, 241 Pu decays to 241 Am with a half-life of about 14 y. The hazard from a mixture which begins as pure 241 Pu increases by about 50% over 60 y (as it transmutes to 241 Am), at which point it begins to drop off again.
In general, the hazard of constituents with shorter half-lives decrease relative to that of constituents with longer half-lives. In addition, the hazard from daughter products may become significant with time. Pu will have largely been replaced by 241 Am, which may become dosimetrically significant.
It follows that the appropriate monitoring of the constituents of plutonium mixtures (both routine and following an incident) is strongly dependent on the age of the mixture. In addition, the routine monitoring threshold of a plutonium mixture (e.g., the mass which necessitates routine bioassay monitoring for at least one constituent) changes with age and might, in rare cases, decrease. Table A5 shows the age at which 241 Am becomes important and 241 Pu becomes less important for the mixtures considered above.
When the age of a mixture is unknown, conservative estimates should be used when making decisions regarding bioassay monitoring. The next example deals with aging mixture in more detail.
Example: Unknown plutonium mixture
For simplicity, the last example assumed that an employee would be working with only one mixture type. In this example, suppose we know only that the employee works with various formulations of MT42, with a maximum age of 30 y. The dose coefficients of these mixtures when new and at age 30 y are shown in Table A6 and A7, respectively. The Table A3 . The monitoring thresholds of each constituent of the plutonium mixtures, as well as the thresholds for the total mixture. The monitoring threshold of the dominant constituent of each mixture is highlighted grey. The constituent monitoring thresholds are the masses (of total mixture) for which a 1 mSv committed effective dose from those radionuclides may be possible. Tables A8 and Table A9 , respectively.
Like the dose coefficients, these either increase or decrease uniformly throughout this time period.
The constituent with the highest relative dose in any mixture type at any age is highlighted grey. These should be assumed for any unmonitored constituents for purposes of considering special bioassay monitoring following an intake. 
